You are here

RAC Vaccines and Vaccination Group

Primary tabs

RAC Workgroup Efforts Focused on Vaccines and Vaccination

The Resilient American Communities (RAC) Vaccines and Vaccination Group is examining and acting on the issues surrounding vaccines development, distribution, vaccination logistics and execution, as well as vaccination strategy, safety, efficacy, trust, and hesitancy.  Special attention is currently focused on COVID-19 vaccines and vaccination. 

Members

Hank Rappaport Jan Booher John Girard Kathleen H mdmcdonald mike kraft

Email address for group

rac-vaccination@m.resiliencesystem.org

New statement: AstraZeneca COVID-19 vaccine 76% effective in updated U.S. trial results

After results are questioned, AstraZeneca says complete data shows its vaccine is still highly effective.

https://www.nytimes.com/live/2021/03/24/world/covid-vaccine-coronavirus-cases#after-results-are-questioned-astrazeneca-says-complete-data-shows-its-vaccine-is-still-highly-effective

AstraZeneca reiterated on Wednesday that its Covid-19 vaccine was very effective at preventing the disease, based on more recent data than was included when the company announced the interim results of its U.S. clinical trial on Monday.

The company said in a news release that its vaccine was 76 percent effective at preventing Covid-19. That is slightly lower than the efficacy number that the company announced earlier this week.

Problem, Solution, SitRep, or ?: 

Pages

howdy folks
Page loaded in 0.895 seconds.